Skip to main content

Table 1 Baseline characteristics of patients

From: Relationship between hemoglobin A1c and cardiovascular disease in mild-to-moderate hypercholesterolemic Japanese individuals: subanalysis of a large-scale randomized controlled trial

Variable

Men

Women

Total

n

1374

2628

4002

Age, years

55.5 ± 8.1

59.8 ± 6.0

58.3 ± 7.1

BMI, kg/m2

24.1 ± 2.8

23.8 ± 3.4

23.9 ± 3.2

Diabetes, n (%)

626 (45.6)

870 (33.1)

1496 (37.4)

Hypertension, n (%)

514 (37.4)

1108 (42.2)

1622 (40.5)

Current smoker, n (%)

518 (37.7)

145 (5.5)

663 (16.6)

TC, mmol/L

6.24 ± 0.31

6.29 ± 0.32

6.27 ± 0.32

LDL-C, mmol/L

4.01 ± 0.47

4.08 ± 0.43

4.06 ± 0.45

HDL-C, mmol/L

1.36 ± 0.36

1.54 ± 0.38

1.48 ± 0.38

Non-HDL, mmol/L

4.88 ± 0.46

4.76 ± 0.48

4.80 ± 0.48

TG (median [IQR]), mmol/L

1.71 (1.26-2.45)

1.33 (1.01-1.80)

1.44 (1.08-2.01)

FPG, mmol/L

6.80 ± 2.27

6.15 ± 1.80

6.37 ± 2.00

HbA1c, %

6.47 ± 1.38

6.22 ± 1.16

6.31 ± 1.24

Oral hypoglycemic agent, n (%)

291 (21.2)

423 (16.1)

714 (17.8)

Insulin, n (%)

55 (4.0)

98 (3.7)

153 (3.8)

  1. Values are mean ± SD unless otherwise indicated.
  2. Diabetes and hypertension defined by physician diagnosis. BMI, body mass index; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triacylglycerides; FPG, fasting plasma glucose; IQR, interquartile range.